News & Press Releases

Integrity Applications to Present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference

October 29th, 2013

Integrity Applications to Present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference

Business WirePress Release: Integrity Applications, Inc. – 10 hours ago

RELATED QUOTES

Symbol Price Change
IGAP 8.50 0.00

 

ASHKELON, Israel–(BUSINESS WIRE)–

Integrity Applications, Inc. (IGAP), developer of the GlucoTrack®model DF-F non-invasive blood glucose measurement device, announced that  Avner Gal, the Company’s Chief Executive Officer, will present at the  AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference at 9:00 a.m.  PT on Tuesday, October 29, 2013. The conference will be held at the  Sheraton Seattle Hotel, 1400 Sixth Avenue, Seattle, Washington.

In his presentation, Mr. Gal will discuss the Company’s CE Marked  GlucoTrack® model DF-F non-invasive glucose monitoring  device, designed for spot measuring. GlucoTrack aims to help people with  diabetes obtain blood glucose level measurements without the pain,  inconvenience, incremental cost and difficulty of conventional spot  finger stick devices.

About the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference

This conference is a collaboration between Accredited Members, Inc., a  membership-based financial research firm specializing in small cap/micro  cap research that hosts 3-4 investment conferences annually, and ZINO  Society, a premier membership, business and social network that connects  accredited investors with entrepreneurs seeking funding.

About Integrity Applications, Inc.

Integrity Applications, Inc. is a medical device company focused on the  design, development and commercialization of non-invasive glucose  monitoring devices for use by people with diabetes. Integrity  Applications has developed the GlucoTrack model DF-F non-invasive  glucose monitoring device, which is designed to help people with  diabetes obtain blood glucose level measurements without the pain,  inconvenience, incremental cost, and difficulty of conventional  (invasive) spot finger stick devices. Integrity Applications works  primarily through its wholly-owned Israeli subsidiary, A.D. Integrity  Applications, Ltd. For more information please visit www.integrity-app.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning  of the Private Securities Litigation Reform Act of 1995. Statements  contained in this news release that are not statements of historical  fact may be deemed to be forward-looking statements. Without limiting  the generality of the foregoing, words such as “will,” and “believe,”  are intended to identify forward-looking statements. Readers are  cautioned that certain important factors may affect Integrity  Applications’ actual results and could cause such results to differ  materially from any forward-looking statements that may be made in this  news release. Factors that may affect Integrity Applications’ results  include, but are not limited to, the ability of Integrity applications  to successfully commercialize the GlucoTrack DF-F; the ability of the  GlucoTrack DF-F to achieve acceptable pricing, adequate third party  reimbursement or market acceptance; the ability of Integrity  Applications to manage its growth and the expansion of its operations to  include commercialization activities; risks relating to the use of third  party manufacturers; risks relating to the development of Integrity  Applications’ sales, marketing and distribution capability, either on  its own or through collaborations with marketing partners; and the  additional risk factors described in Integrity Applications’ filings  with the U.S. Securities and Exchange Commission, including its Annual  Report on Form 10-K for the year ended December 31, 2012.

 

Contact:
Integrity Applications Avner Gal, President and CEO +972 (8) 675-7878 info@integrity-app.com or
Dian Griesel Int’l. Investor Relations: Cheryl Schneider Public Relations: Susan Forman or Laura Radocaj +1 (212) 825-3210 cschneider@dgicomm.com

Back to all news & press releases

Sign up to our newsletter
To receive occasional news updates

LinkedIn Facebook Twitter